Alliance Pharma PLC Exercise of Share Options (1688K)
April 15 2015 - 02:01AM
UK Regulatory
TIDMAPH
RNS Number : 1688K
Alliance Pharma PLC
15 April 2015
For immediate release 15 April 2015
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Exercise of Share Options
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, announces that, following the exercise of employee share
options, application has been made by Alliance for a further 36,499
ordinary shares of 1 pence each in the Company ("Ordinary Shares")
to be admitted to trading on AIM.
It is expected that these new Ordinary Shares, which will rank
pari passu in all respects with the existing Ordinary Shares, will
be admitted to trading on 20 April 2015.
Following the exercise of the options, Alliance will have
264,199,164Ordinary Shares in issue.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
+ 44 (0) 20 7466
Buchanan 5000
Mark Court / Sophie Cowles
/ Jane Glover
+ 44 (0) 20 7260
Numis Securities Limited 1000
Nominated Adviser: Michael
Meade / Freddie Barnfield
Corporate Broking: David
Poutney
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality
pharmaceutical company based in Chippenham, Wiltshire, UK. The
Company has a strong track record of acquiring the rights to
established niche products and owns or licenses the rights to more
than 60 pharmaceutical products and continues to explore
opportunities to expand the range.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFLLSFISLIE
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Feb 2024 to Mar 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2023 to Mar 2024